G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,475 | +32.0% | 19,082 | +128.1% | 0.00% | – |
| Q2 2023 | $20,809 | +62.4% | 8,364 | +74.5% | 0.00% | – |
| Q1 2023 | $12,814 | -1.4% | 4,793 | +94.5% | 0.00% | – |
| Q4 2022 | $13,000 | -87.6% | 2,464 | -70.8% | 0.00% | – |
| Q3 2022 | $105,000 | +356.5% | 8,427 | +87.0% | 0.00% | – |
| Q2 2022 | $23,000 | -88.1% | 4,507 | +396.4% | 0.00% | – |
| Q1 2022 | $193,000 | +3116.7% | 908 | +62.7% | 0.00% | – |
| Q4 2021 | $6,000 | -71.4% | 558 | -65.9% | 0.00% | – |
| Q3 2021 | $21,000 | -67.2% | 1,636 | -43.5% | 0.00% | – |
| Q2 2021 | $64,000 | -74.4% | 2,896 | -72.2% | 0.00% | -100.0% |
| Q1 2021 | $250,000 | +290.6% | 10,402 | +192.1% | 0.00% | – |
| Q4 2020 | $64,000 | +326.7% | 3,561 | +447.8% | 0.00% | – |
| Q2 2020 | $15,000 | -63.4% | 650 | -82.5% | 0.00% | – |
| Q1 2020 | $41,000 | – | 3,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |